通过向EGFR/AKT/ERK1/2信号通路来抑制人类冠状病毒HCoV-OC43
Yuanyuan Huang1,2, Jieyu Li1,2, Qiting Luo2
1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Viruses
|August 28, 2025
概括
4-基 (4HCH) 对人类冠状病毒HCoV-OC43具有强烈的抗病毒作用. 这种化合物通过向表皮生长因子受体 (EGFR) 途径来抑制病毒复制,为新型冠状病毒治疗提供了潜力.
科学领域:
- 病毒学
- 药理学
- 免疫学
背景情况:
- 人类冠状病毒对全球健康构成重大威胁.
- 迫切需要针对冠状病毒的有效抗病毒疗法.
研究的目的:
- 调查4-甲基 (4HCH) 对人类冠状病毒HCoV-OC43的抗病毒活性.
- 阐明4HCH对HCoV-OC43感染的作用机制.
主要方法:
- 在体外测试以评估细胞病变抑制,病毒蛋白和RNA水平.
- 使用 HCoV-OC43 感染的哺乳小鼠进行体内研究以评估生存率.
- 对表皮生长因子受体 (EGFR) 信号通路和促炎细胞因子的分析.
主要成果:
- 4HCH显著抑制了HCoV-OC43的细胞病变效应,病毒载量,并增加了感染小鼠的存活率.
- 4HCH通过与EGFR结合,抑制EGFR/ AKT/ ERK1/ 2通路,并抑制病毒复制的早期病毒感染阶段.
- 在受感染细胞和动物模型中,4HCH降低了促炎性细胞因子和化学因子的产生.
结论:
- 4HCH在体外和体内表现出对HCoV-OC43的强烈抗病毒活性.
- EGFR被认为是开发新型抗病毒药物的有前途的宿主目标.
- 4HCH是治疗人类冠状病毒感染的潜在候选药物.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


